TechNavio today launched its report Global Leukemia Therapeutics Market 2012-2016 based on an in-depth analysis covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the significant trends impacting this market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said: ”There has been increase in the volume of medical tourism in the APAC region. Patients from all around the world are visiting countries such as China and India for various treatments. Healthcare facilities in the APAC region are improving and there is an excellent range of healthcare providers that are offering good-quality treatment for diseases such as cancer and other treatments at low cost. Thus the increasing number of patients going to China and India for cancer treatment is a growing trend that is influencing the healthcare organizations in the region to purchase more therapeutic drugs for the treatment of leukemia.”
According to the report, one of the major factors driving the growth of the Global Leukemia Therapeutics market is the increasing prevalence of cancer patients worldwide. Therapeutic drugs are among the remedies for cancer and hence healthcare organizations across the globe are opting for therapeutic drugs in the treatment of leukemia. However, most of the vendors are focusing on the US market, which is expected to witness a faster growth rate than the global market over the period 2012-2016.
Further, the report states that the delay in diagnosing cancer is one of the major challenges in the Global Leukemia Therapeutics Market.
The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this market space are Bristol-Myers Squibb Co., Celgene Corp., GlaxoSmithKline plc, Hoffmann-La Roche Ltd., Novartis AG. The other vendors mentioned in the report are Ambit Biosciences Inc., ARIAD Pharmaceuticals Inc., Biogen Idec Inc., Cephalon Inc., Clavis Pharma ASA, Eisai Co. Ltd., ERYtech Pharma SA, Genmab A/S, Pfizer Inc., Sunesis Pharmaceuticals Inc., Talon Therapeutics Inc., Teva Pharmaceutical Industries Ltd..
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/content/global-leukemia-therapeutics-market-201…
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our Healthcare market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research Report – Global Leukemia Therapeutics Market 2012-2016
